Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | M.K.BROTHERSLikely | 1 | ₹13.8 L |
| 2 | Schedule 2 | Not yet disclosed by govt.Likely | 11 | - |
| 3 | Schedule 3 | Not yet disclosed by govt.Likely | 11 | - |
| 4 | Schedule 4 | TRISHA ENTERPRISESLikely | 2 | ₹4,140 |
| 5 | Schedule 5 | JSB PHARMACEUTICALSLikely | 4 | ₹909 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
17 Jan 2026, 9:00 amClosed
Tab Niraparib 100 mg
Tab Acarbose 50 mg
Aceclofenac 100 mg paracetamol 325 mg chloroxazone 250 mg
Acetaminophen 325 mg tramadol 37.5 mg
Acyclovir 400 mg
8693816
GEM/2025/B/6983200
Two Packet Bid
Tab Niraparib 100 mg
15 days
Madhya Pradesh; Bhopal
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹5 L
₹10 L
30%
Exempted
17 Jan 2026
6 Jan 2026
17 Jan 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | Tab Niraparib 100 mg | 168 | NO | BHOPAL | 15 | |
| 2 | Tab Acarbose 50 mg | 600 | NO | BHOPAL | 15 | - |
| 3 | Aceclofenac 100 mg paracetamol 325 mg chloroxazone 250 mg | 9,000 | NO | BHOPAL | 15 | |
| 4 | Acetaminophen 325 mg tramadol 37.5 mg | 3,000 | NO | BHOPAL | 15 | |
| 5 | Acyclovir 400 mg | 300 | NO | BHOPAL | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8693816.pdf
GEM_BID
specification_10_12_2025_2025-12-10-12-30-06_29684b73774fd4c07396c1a494807976.pdf
BOQ
boq_item_sample_file-5_2025-12-10-12-30-06_4133452b85de33740619874223ee8e5a.csv
BOQ
1765441047.pdf
OTHER
ATCDOCUMTS_61ec1f75-0cfd-48da-99861765441083061_DGLP1.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .